GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (OSL:CELL) » Definitions » Cash Ratio

CellCura ASA (OSL:CELL) Cash Ratio : 0.00 (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. CellCura ASA's Cash Ratio for the quarter that ended in Jun. 2014 was 0.00.

CellCura ASA has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for CellCura ASA's Cash Ratio or its related term are showing as below:

OSL:CELL's Cash Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.93
* Ranked among companies with meaningful Cash Ratio only.

CellCura ASA Cash Ratio Historical Data

The historical data trend for CellCura ASA's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Cash Ratio Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cash Ratio
Get a 7-Day Free Trial 1.06 1.08 0.28 0.03 0.01

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.07 0.01 0.01 -

Competitive Comparison of CellCura ASA's Cash Ratio

For the Biotechnology subindustry, CellCura ASA's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Cash Ratio distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Cash Ratio falls into.



CellCura ASA Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

CellCura ASA's Cash Ratio for the fiscal year that ended in Dec. 2013 is calculated as:

Cash Ratio (A: Dec. 2013 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.226/19.321
=0.01

CellCura ASA's Cash Ratio for the quarter that ended in Jun. 2014 is calculated as:

Cash Ratio (Q: Jun. 2014 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.113/24.832
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (OSL:CELL) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


CellCura ASA Cash Ratio Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (OSL:CELL) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.